We could not find any results for:
Make sure your spelling is correct or try broadening your search.
Share Name | Share Symbol | Market | Type | Share ISIN | Share Description |
---|---|---|---|---|---|
Marwyn Acquisition Company Plc | LSE:MACP | London | Ordinary Share | JE00BZBYC658 | ORD NPV |
Bid Price | Offer Price | High Price | Low Price | Open Price | |
---|---|---|---|---|---|
1.75 | 2.00 |
Industry Sector | Turnover | Profit | EPS - Basic | PE Ratio | Market Cap |
---|---|---|---|---|---|
- |
Last Trade Time | Trade Type | Trade Size | Trade Price | Currency |
---|---|---|---|---|
- | O | 0 | 1.875 | GBX |
Marwyn Acquisition (MACP) Share Charts1 Year Marwyn Acquisition Chart |
|
1 Month Marwyn Acquisition Chart |
Intraday Marwyn Acquisition Chart |
Trade Time | Trade Price | Trade Size | Trade Value | Trade Type |
---|
Top Posts |
---|
Posted at 31/3/2021 07:36 by irishlass2 Would be a great target for MACP. |
Posted at 18/3/2021 18:46 by pass the dutchy ANA will be the UK’s leading cannabis producer (200 TONS per year that’s worth £400m)Share price 1.45p Only £8m mkt cap Fastest growing sector worldwide Will have first mover advantage in UK Same growers as GW Pharma (just got sold for £5b) 4 biggest shareholders hold over 50% BOD own 30% Massively undervalued Near term multi bagger on license approval Partners with leading prof , scientists etc Primed for a RTO/ main listing (price driver) Under the radar (most chased MXC,CBX) Looking to bring a product to market Off take agreement in place already Will be producing 200 TONS per year (200,000 kilos) Has the most land out of every UK cannabis co (40 hectares) Fully funded for phase 1 UK medical cannabis growing 20% month Only 584m shares in issue Hardly any available in open market Will apply for a commercial license too |
It looks like you are not logged in. Click the button below to log in and keep track of your recent history.
Support: +44 (0) 203 8794 460 | support@advfn.com
By accessing the services available at ADVFN you are agreeing to be bound by ADVFN's Terms & Conditions